Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide.
Saved in:
| Title: | Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide. |
|---|---|
| Authors: | Draeger KE; Glimepiride Multicentre Study Group, Hoechst AG, Frankfurt, Germany., Wernicke-Panten K, Lomp HJ, Schüler E, Rosskamp R |
| Source: | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme [Horm Metab Res] 1996 Sep; Vol. 28 (9), pp. 419-25. |
| Publication Type: | Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Thieme Country of Publication: Germany NLM ID: 0177722 Publication Model: Print Cited Medium: Print ISSN: 0018-5043 (Print) Linking ISSN: 00185043 NLM ISO Abbreviation: Horm Metab Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
